Drug Shortage Report for ACETAMINOPHEN, CAFFEINE & CODEINE
Report ID | 43848 |
Drug Identification Number | 02028174 |
Brand name | ACETAMINOPHEN, CAFFEINE & CODEINE |
Common or Proper name | ACET CODEINE |
Company Name | PHARMASCIENCE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE |
Strength(s) | 300MG 8MG 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N02AJ |
ATC description | OPIOIDS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-03-23 |
Estimated end date | Unknown |
Actual end date | 2020-06-05 |
Shortage status | Resolved |
Updated date | 2020-06-09 |
Company comments | in process of deactivation Product already discontinued DIN cancelled post market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-23 | English | Compare |
v2 | 2018-03-23 | French | Compare |
v3 | 2018-03-24 | English | Compare |
v4 | 2020-06-09 | English | Compare |
v5 | 2020-06-09 | French | Compare |
Showing 1 to 5 of 5